141 related articles for article (PubMed ID: 18289097)
1. N-myristoyltransferase: a novel target.
Prasad KK; Toraskar MP; Kadam VJ
Mini Rev Med Chem; 2008 Feb; 8(2):142-9. PubMed ID: 18289097
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the discovery of N-myristoyltransferase inhibitors.
Zhao C; Ma S
ChemMedChem; 2014 Nov; 9(11):2425-37. PubMed ID: 25125080
[TBL] [Abstract][Full Text] [Related]
3. N-myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: protein N-myristoyltransferase.
Lodge JK; Jackson-Machelski E; Devadas B; Zupec ME; Getman DP; Kishore N; Freeman SK; McWherter CA; Sikorski JA; Gordon JI
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():357-366. PubMed ID: 9043113
[TBL] [Abstract][Full Text] [Related]
4. Mammalian myristoyl CoA: protein N-myristoyltransferase.
Raju RV; Magnuson BA; Sharma RK
Mol Cell Biochem; 1995; 149-150():191-202. PubMed ID: 8569729
[TBL] [Abstract][Full Text] [Related]
5. Substrate specificity of Saccharomyces cerevisiae myristoyl-CoA: protein N-myristoyltransferase. Analysis of fatty acid analogs containing carbonyl groups, nitrogen heteroatoms, and nitrogen heterocycles in an in vitro enzyme assay and subsequent identification of inhibitors of human immunodeficiency virus I replication.
Devadas B; Lu T; Katoh A; Kishore NS; Wade AC; Mehta PP; Rudnick DA; Bryant ML; Adams SP; Li Q
J Biol Chem; 1992 Apr; 267(11):7224-39. PubMed ID: 1559967
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of Candida albicans N-myristoyltransferase with two distinct inhibitors.
Sogabe S; Masubuchi M; Sakata K; Fukami TA; Morikami K; Shiratori Y; Ebiike H; Kawasaki K; Aoki Y; Shimma N; D'Arcy A; Winkler FK; Banner DW; Ohtsuka T
Chem Biol; 2002 Oct; 9(10):1119-28. PubMed ID: 12401496
[TBL] [Abstract][Full Text] [Related]
7. Structure of N-myristoyltransferase from Aspergillus fumigatus.
Shimada T; Suzuki M; Katakura S
Acta Crystallogr D Biol Crystallogr; 2015 Apr; 71(Pt 4):754-61. PubMed ID: 25849386
[TBL] [Abstract][Full Text] [Related]
8. Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.
Sikorski JA; Devadas B; Zupec ME; Freeman SK; Brown DL; Lu HF; Nagarajan S; Mehta PP; Wade AC; Kishore NS; Bryant ML; Getman DP; McWherter CA; Gordon JI
Biopolymers; 1997; 43(1):43-71. PubMed ID: 9174411
[TBL] [Abstract][Full Text] [Related]
9. Antifungals targeted to protein modification: focus on protein N-myristoyltransferase.
Georgopapadakou NH
Expert Opin Investig Drugs; 2002 Aug; 11(8):1117-25. PubMed ID: 12150705
[TBL] [Abstract][Full Text] [Related]
10. Characterization and selective inhibition of myristoyl-CoA:protein N-myristoyltransferase from Trypanosoma brucei and Leishmania major.
Panethymitaki C; Bowyer PW; Price HP; Leatherbarrow RJ; Brown KA; Smith DF
Biochem J; 2006 Jun; 396(2):277-85. PubMed ID: 16480339
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of action of NIP71 on N-myristoyltransferase activity.
King MJ; Sharma RK
Mol Cell Biochem; 1994 Dec; 141(2):79-86. PubMed ID: 7891674
[TBL] [Abstract][Full Text] [Related]
12. The structure of myristoyl-CoA:protein N-myristoyltransferase.
Bhatnagar RS; Fütterer K; Waksman G; Gordon JI
Biochim Biophys Acta; 1999 Nov; 1441(2-3):162-72. PubMed ID: 10570244
[TBL] [Abstract][Full Text] [Related]
13. FTR1335 is a novel synthetic inhibitor of Candida albicans N-myristoyltransferase with fungicidal activity.
Ebara S; Naito H; Nakazawa K; Ishii F; Nakamura M
Biol Pharm Bull; 2005 Apr; 28(4):591-5. PubMed ID: 15802792
[TBL] [Abstract][Full Text] [Related]
14. Development of an enzyme-linked immunosorbent assay for measurement of activity of myristoyl-coenzyme A:protein N-myristoyltransferase.
Takamune N; Hamada H; Sugawara H; Misumi S; Shoji S
Anal Biochem; 2002 Oct; 309(1):137-42. PubMed ID: 12381372
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
16. Altered membrane association of p60v-src and a murine 63-kDa N-myristoyl protein after incorporation of an oxygen-substituted analog of myristic acid.
Heuckeroth RO; Gordon JI
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5262-6. PubMed ID: 2501783
[TBL] [Abstract][Full Text] [Related]
17. A novel inhibitor protein of N-myristoyltransferase from Escherichia coli.
Gowda S; Shrivastav A; Selvakumar P; Dimmock JR; Sharma RK
Biochem Biophys Res Commun; 2004 Feb; 314(4):984-7. PubMed ID: 14751229
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of protein N-myristoylation: a therapeutic protocol in developing anticancer agents.
Das U; Kumar S; Dimmock JR; Sharma RK
Curr Cancer Drug Targets; 2012 Jul; 12(6):667-92. PubMed ID: 22463587
[TBL] [Abstract][Full Text] [Related]
19. Effects of L-histidine and its structural analogues on human N-myristoyltransferase activity and importance of EEVEH amino acid sequence for enzyme activity.
Raju RV; Datla RS; Warrington RC; Sharma RK
Biochemistry; 1998 Oct; 37(42):14928-36. PubMed ID: 9778369
[TBL] [Abstract][Full Text] [Related]
20. Myristoyl CoA:protein N-myristoyltransferase: subcellular localization, activation and kinetic behavior in the presence of organic solvents.
Rajala RV; Sharma RK
Biochem Biophys Res Commun; 1995 Mar; 208(2):617-23. PubMed ID: 7695615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
